Page last updated: 2024-10-26
diclofenac and Central Diabetes Insipidus
diclofenac has been researched along with Central Diabetes Insipidus in 1 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Research Excerpts
Excerpt | Relevance | Reference |
" The results indicated uniform trend to an increase in the number of clathrincoated vesicles under conditions of hormone treatment combined with prostaglandin synthesis blockade in animals with different neurohypophyseal status." | 1.43 | Electron Microscopic Study of the Inner Medulla in Rat Kidneys under Conditions of Vasopressin Treatment Combined with Prostaglandin Synthesis Blockade. ( Babina, AV; Lavrinenko, VA, 2016) |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
Babina, AV | 1 |
Lavrinenko, VA | 1 |
Clinical Trials (1)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status |
Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium[NCT05188131] | Phase 4 | 12 participants (Actual) | Interventional | 2021-10-01 | Completed |
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
1 other study available for diclofenac and Central Diabetes Insipidus